Asia-Pacific: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in Asia-Pacific

In 2021, the Asia-Pacific market for medicaments of alkaloids or derivatives thereof decreased by -X% to $X for the first time since 2014, thus ending a six-year rising trend. The total consumption indicated a prominent increase from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +X% against 2014 indices. Over the period under review, the market reached the peak level at $X in 2020, and then dropped modestly in the following year.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in Asia-Pacific

In value terms, production of medicaments of alkaloids or derivatives thereof dropped to $X in 2021 estimated in export price. The total production indicated a temperate increase from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +X% against 2014 indices. The pace of growth appeared the most rapid in 2019 when the production volume increased by X%. The level of production peaked at $X in 2020, and then dropped modestly in the following year.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports in Asia-Pacific

In 2021, exports of medicaments of alkaloids or derivatives thereof in Asia-Pacific totaled X tons, remaining relatively unchanged against the previous year. Over the period under review, exports, however, saw a abrupt decrease. The most prominent rate of growth was recorded in 2014 with an increase of X%. The volume of export peaked at X tons in 2012; however, from 2013 to 2021, the exports failed to regain momentum.

In value terms, exports of medicaments of alkaloids or derivatives thereof declined modestly to $X in 2021. Overall, exports, however, showed a deep slump. The most prominent rate of growth was recorded in 2019 when exports increased by X%. The level of export peaked at $X in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

China (X tons), Hong Kong SAR (X tons) and India (X tons) represented roughly X% of total exports in 2021. New Zealand (X tons), Australia (X tons) and Pakistan (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were in Pakistan (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, China ($X) remains the largest medicaments of alkaloids or derivatives thereof supplier in Asia-Pacific, comprising X% of total exports. The second position in the ranking was held by Hong Kong SAR ($X), with an X% share of total exports. It was followed by India, with a X% share.

In China, exports of medicaments of alkaloids or derivatives thereof increased at an average annual rate of +X% over the period from 2012-2021. The remaining exporting countries recorded the following average annual rates of exports growth: Hong Kong SAR (+X% per year) and India (-X% per year).

Export Prices by Country

In 2021, the export price in Asia-Pacific amounted to $X per ton, reducing by -X% against the previous year. Overall, the export price continues to indicate a perceptible downturn. The most prominent rate of growth was recorded in 2013 an increase of X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2014 to 2021, the the export prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Australia ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Hong Kong SAR (+X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports in Asia-Pacific

For the fourth year in a row, Asia-Pacific recorded growth in overseas purchases of medicaments of alkaloids or derivatives thereof, which increased by X% to X tons in 2021. Over the period under review, imports, however, saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 with an increase of X% against the previous year. Over the period under review, imports of reached the maximum at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, imports of medicaments of alkaloids or derivatives thereof rose slightly to $X in 2021. Overall, imports saw a relatively flat trend pattern. The growth pace was the most rapid in 2014 when imports increased by X%. The level of import peaked in 2021 and is likely to see steady growth in years to come.

Imports by Country

The countries with the highest levels of imports of medicaments of alkaloids or derivatives thereof in 2021 were Japan (X tons), Australia (X tons), South Korea (X tons), Malaysia (X tons) and China (X tons), together resulting at X% of total import. The following importers - Indonesia (X tons) and Singapore (X tons) - each amounted to a X% share of total imports.

From 2012 to 2021, the biggest increases were in Singapore (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, China ($X), Malaysia ($X) and Japan ($X) appeared to be the countries with the highest levels of imports in 2021, together accounting for X% of total imports. These countries were followed by Australia, South Korea, Indonesia and Singapore, which together accounted for a further X, with a CAGR of +X%, recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia-Pacific stood at $X per ton in 2021, standing approx. at the previous year. Over the last nine years, it increased at an average annual rate of +X%. The pace of growth was the most pronounced in 2014 an increase of X%. As a result, import price reached the peak level of $X per ton. From 2015 to 2021, the import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was China ($X per ton), while Singapore ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Malaysia (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :